Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-038087
Filing Date
2024-08-21
Accepted
2024-08-21 19:51:32
Documents
3
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1724284286.html 3  
1 FORM 3 wk-form3_1724284286.xml 3 2221
2 EX-24 poa_antunes1.htm EX-24 630
3 poa_antunes1001.jpg GRAPHIC 243463
  Complete submission text file 0001628280-24-038087.txt   339796
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVADIM HEALTH, INC. 81 THOMPSON STREET ASHEVILLE NC 28803
Business Address
Antunes Humberto Calheiros (Reporting) CIK: 0001800145 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 241229863